Complementary changes
October 28, 2011
A NEW era has dawned for
complementary medicine with the
unveiling of the Complementary
Healthcare Council of Australia’s
(CHC) new look.
Revealed yesterday at the CHC’s
National Conference in Sydney, the
new logo has been designed to
reflect the maturation of the
industry and the CHC’s desire to be
taken seriously as a peak industry
body rather than a members
association.
The launch marks the first time in
15 years that the CHC have made a
design change, with a spokesperson
saying the refreshed logo is
symbolic of a paradigm shift in the
organisation and is indicative of its
focus on industry best outcomes as
well as its co-ordination between
nature, science and health for all
Australians.
Addressing National Conference
delegates, CHC Executive Director,
Dr Wendy Morrow said the new
look and feel represents the CHC of
today and the future “An Australian
professional revitalised recognised
and authoritative entity playing a
crucial role in the preventative
health agenda and areas of
industry policy, health policy and
regulatory policy”.
As part of this revitalisation the
CHC Board has worked up a
number of key priorities for the
organisation over the coming phase
which include the establishment of
Australian/NZ therapeutics agency.
“We support the government’s
decision to pursue that agenda and
to exclude complementary
medicines from the original model,
we do believe that gives us an
opportunity to look at whether
there is a better regulatory
structure for complementary
medicines for Australia potentially
along the lines of what’s happened
in New Zealand,” said President of
the CHC, Richard Henfrey.
“Given the state of the current
regulatory environment the CHC
must act proactively to captalise on
the increased focus on the
preventative health agenda,” he
added.
The CHC is also now focusing in
on an issue dear to many in the
healthcare profession: government
funding for research and
development of complementary
medicines, including scientific
research, clinical trials and cost
effectiveness.
A further focus for the CHC over
the coming phase is improved
export conditions to provide a level
playing field for Australian
manufacturers and brands.
And finally the CHC said it will
also mount a major push for
supported industry innovation in
terms of easier pathways to
intellectual property protection.
“We’ve got a pretty busy program
of work ahead,” Henfrey said.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Oct 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Oct 11
